Strides Pharma Science Limited has informed the Exchange about movement in Senior Management Personnel of the Company.
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Strides Pharma Science has informed exchanges about changes in its Senior Management Personnel (SMP). Two members — Ms. Sangeetha K (Head of Regulatory Affairs) and Ms. Bharathi R (Head of Global Procurement) — stepped down from SMP roles on March 31, 2025 and April 30, 2025 respectively, after moving into advisory roles within group companies. Separately, Mr. K N Swamy (Head of Global Analytical – Development & Services) and Mr. Sugeet Chopra (Head of Procurement and Supply Chain) were inducted into the SMP category effective May 1, 2025. Sugeet Chopra, an internal hire since March 2022, has additionally taken over the Procurement function and brings 14+ years of operations and supply chain experience from Fresenius Kabi, Dow Chemical and others.
This appears to be routine internal restructuring rather than a leadership vacuum — both outgoing members continue within the group in advisory capacities, and key functions (Procurement, Supply Chain, Analytical) have replacements lined up. Shareholders are unlikely to see meaningful stock price impact from this disclosure.